The American company and the German BioNTech have announced that they have already developed a vaccine with an efficacy of 95%.
He coronavirus has changed our lives . The pandemic has changed the way we live and has affected millions of people around the world and so there is an urgent search for a vaccine that can change this situation.
In this sense, German pharmaceutical Pfizer and its partner BioNTech They have announced that they have found a vaccine that is “90%” effective after the tests they have done over the past few weeks and that in the latest study they have increased the effectiveness to 95%,
“Today is a great day for science and humanity. The results show that our mRNA-based vaccine can help prevent COVID-19 in the majority of people who get it. This means we are one step closer to providing of it to people around the world is a much-needed breakthrough to end this global pandemic,” said Albert Bourla, CEO of Pfizer.
When will it be available, how much will it cost and how and where to get it
Salvador Illa, Minister of Health, has already set a date for the start of vaccination in Spain. “Vaccination in Spain started on December 27 after we received the first doses of the Pfizer vaccine the day before. Weekly doses will be received that will be distributed fairly among the Autonomous Communities and administered as determined in the national strategy. is the beginning of the end of the pandemic, but it is not the end. We will have to continue to take measures and continue to take responsibility,” says Illa.
A public retirement home in Guadalajara was the first to receive it. Araceli, 96, and Mónica, a nurse, were the first two people in Spain to get it.
With them begins the vaccination, the first phase of which aims to cover 2.3 million people in the next 12 weeks.
The two companies will receive approval this month to approve the vaccine and begin urgent distribution to the public: “We have reached this critical milestone in our vaccine development program at a time when the world needs it most.”
In fact, the effect of the news is already being felt in the economy, where stock markets grew by 8% this Monday.
However, it is not the only option as the American company Moderna has also marketed its vaccine with an effectiveness of 94.5%. Also China, Spain, Australia, United States, Germany (of Dietmar Hopp the hated owner of the Hoffenheim to the head) and England they are working on forced marches, with the latter apparently having the advantage. members of the Jenner Institute belonging to the oxford university, claimed their hypothetical vaccine (called hAdOx1 nCoV-19) had passed a critical stage Positive results : healed six resu macaques the animal most closely resembling humans from a biological point of view.
Now it was CureVac, Hopp’s, who reported “positive preclinical results at low doses.” What follows, as announced, are the human testing .
modern , an American company, has announced that it already has results of the tests it has performed on 45 patients with COVID-19. They reported that the tests were “safe and generally well tolerated.”
The University of Oxford, in conjunction with the pharmaceutical AstraZeneca, reported that the test was safe in more than 1,000 people and that he developed immunity in late July. The two entities had said the results are promising, although they announced on September 8 the temporary suspension of tests due to “possible side effects” in one of the volunteers who received the dose in the UK. While the news caused alarm, the scientific community clarified that it is a matter of protocol, which is common in this type of research. Although it was initially speculated that the drug would be available in September 2020 ; we will definitely have to wait a little longer.
Source: Goal